$HSTO

Histogen Inc

  • NASDAQ
  • Health Technology
  • Biotechnology
  • Pharmaceuticals: Major
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

PRICE

$0.8701 ▼-4.385%

Extented Hours

VOLUME

32,472

DAY RANGE

0.87 - 0.939

52 WEEK

0.6822 - 4.76

Join Discuss about HSTO with like-minded investors

profile
@Chano #StockTraders.NET
recently

tried to short HSTO since open but the turd never bouced, what a shame!

150 Replies 6 👍 9 🔥

profile
@dros #droscrew
recently

+Initiations 8/30: $ADS $AVTR $COOK $DUOL $EWCZ $HSTO $KMT $KRTX $LEVI $MRSN $NRZ $PTRA $RRGB $SITM $SYF $TEAM $WEBR  . -Initiations 8/30: $TPIC

76 Replies 8 👍 12 🔥

profile
@viking #StockTraders.NET
recently

Upside: -CYCN +16% (announces Global Licensing agreement with Akebia Therapeutics for Praliciguat; eligible to receive up to $585M in milestone payments) -SFIX +12% (earnings, guidance) -REVG +10% (earnings, guidance) -CHS +9.9% (earnings, guidance) -EVOK +8.4% (announces FDA Orange Book Listing of U.S. Patent for Gimoti) -ASO +7.2% (earnings, guidance) -MCF +6.6% (to be acquired by Independence Energy in all stock transaction valued at ~$5.7B) -JILL +6.3% (earnings, guidance) -MRVL +5.6% (earnings, guidance) -BYSI +4.8% (announces a Late-Breaking Poster Presentation of PROTECTIVE-2 Phase 3 Data) -THO +4.1% (earnings) -STX +3.7% (raises guidance) -TSLA +2.9% (strong China May passenger vehicle sales) -INO +2.6% (expands partnership with Advaccine to conduct global Phase III efficacy trial of COVID-19 DNA vaccine candidate, INO-4800) -OTLK +2.3% (reports completion of patient dosing in the ONS-5010 Pivotal Phase 3 NORSE TWO Trial) -FTCI +1.4% (earnings, guidance; raising prices) -LUV +1.2% (guidance) Downside: -PLBY -10% (files to offer 4.0M shares) -COUP -8.9% (earnings, guidance; Tony Tiscornia promoted to CFO) -TIGR -7.6% (files to sell 6.5M ADS) -HSTO -7.5% (announces 6.0M share direct offering priced at $1.10/shr) -LESL -5.7% (to sell 24.5M shares for holders) -HQY -5.5% (earnings, guidance) -KDP -4.9% (files to sell 28M common share secondary offering on behalf of Mondelez International) -FTCI -4.7% (earnings, guidance; raising prices) -FSLY -1.7% (hearing Fastly edge CDN platform is having issues causing internet outages) -ETSY -1.3% (files proposed private offering of $1.0B of convertible senior notes) -WBA -1.3% (AMZN reportedly to offer discounted pharmacy services targeting uninsured and those paying cash)

121 Replies 14 👍 15 🔥

Key Metrics

Market Cap

4.01 M

Beta

0.09

Avg. Volume

65.85 K

Shares Outstanding

4.27 M

Yield

0%

Public Float

0

Next Earnings Date

2023-08-10

Next Dividend Date

Company Information

a regenerative medicine company based on naturally-produced products from newborn fibroblasts grown in a proprietary bioreactor. two product families - a proprietary liquid complex of embryonic-like proteins and growth factors, and a human extracellular matrix (ecm) material, exceltrix.

CEO: Steven Mento

Website:

HQ: 10655 Sorrento Valley Road San Diego, 92121 California

Related News